The effects of treatment with antipsychotics on N-acetylaspartate measures in patients with schizophrenia

被引:0
|
作者
Bertolino, A [1 ]
Callicott, JH [1 ]
Elman, I [1 ]
Mattay, VS [1 ]
Weidenhammer, KM [1 ]
Breier, A [1 ]
Frank, JA [1 ]
Pickar, D [1 ]
Weinberger, DR [1 ]
机构
[1] NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S0920-9964(00)90847-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
B121
引用
收藏
页码:219 / 219
页数:1
相关论文
共 50 条
  • [1] The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia
    Bertolino, A
    Callicott, JH
    Mattay, VS
    Weidenhammer, KM
    Rakow, R
    Egan, MF
    Weinberger, DR
    [J]. BIOLOGICAL PSYCHIATRY, 2001, 49 (01) : 39 - 46
  • [2] Decreased cerebellar N-acetylaspartate in schizophrenia
    Johnson, C
    Schuff, N
    Deicken, RF
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 133S - 134S
  • [3] Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia
    Jarskog, L. Fredrik
    Dong, Zhengchao
    Kangarlu, Alayar
    Colibazzi, Tiziano
    Girgis, Ragy R.
    Kegeles, Lawrence S.
    Barch, Deanna M.
    Buchanan, Robert W.
    Csernansky, John G.
    Goff, Donald C.
    Harms, Michael P.
    Javitt, Daniel C.
    Keefe, Richard S. E.
    McEvoy, Joseph P.
    McMahon, Robert P.
    Marder, Stephen R.
    Peterson, Bradley S.
    Lieberman, Jeffrey A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 (07) : 1245 - 1252
  • [4] Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia
    L Fredrik Jarskog
    Zhengchao Dong
    Alayar Kangarlu
    Tiziano Colibazzi
    Ragy R Girgis
    Lawrence S Kegeles
    Deanna M Barch
    Robert W Buchanan
    John G Csernansky
    Donald C Goff
    Michael P Harms
    Daniel C Javitt
    Richard SE Keefe
    Joseph P McEvoy
    Robert P McMahon
    Stephen R Marder
    Bradley S Peterson
    Jeffrey A Lieberman
    [J]. Neuropsychopharmacology, 2013, 38 : 1245 - 1252
  • [5] N-Acetylaspartylglutamate (NAAG) and N-Acetylaspartate (NAA) in Patients With Schizophrenia
    Jessen, Frank
    Fingerhut, Natascha
    Sprinkart, Alois M.
    Kuehn, Kai-Uwe
    Petrovsky, Nadine
    Maier, Wolfgang
    Schild, Hans-H
    Block, Wolfgang
    Wagner, Michael
    Traeber, Frank
    [J]. SCHIZOPHRENIA BULLETIN, 2013, 39 (01) : 197 - 205
  • [6] Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia
    Deicken, RF
    Johnson, C
    Eliaz, Y
    Schuff, N
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (04): : 644 - 647
  • [7] Frontal lobe N-acetylaspartate and psychopathology in schizophrenia
    Sigmundsson, T.
    Toone, B. K.
    Maier, M.
    Greenwood, K.
    Williams, S. C. R.
    Simmons, A.
    Ron, M. A.
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2006, 60 (04) : 320 - 320
  • [8] Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia
    Callicott, JH
    Bertolino, A
    Egan, MF
    Mattay, VS
    Langheim, FJP
    Weinberger, DR
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (10): : 1646 - 1651
  • [9] Lower concentration of thalamic N-acetylaspartate in patients with schizophrenia:: A replication study
    Ende, G
    Braus, DF
    Walter, S
    Henn, FA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (08): : 1314 - 1316
  • [10] The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia
    Bertolino, A
    Knable, MB
    Saunders, RC
    Callicott, JH
    Kolachana, B
    Mattay, VS
    Bachevalier, J
    Frank, JA
    Egan, M
    Weinberger, DR
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (06) : 660 - 667